Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C

  • Technology appraisal guidance
  • TA200
  • Published: 
Download guidance (PDF)

Update information

Minor changes since publication

February 2014: The implementation section was updated to clarify that peginterferon alfa and ribavirin is recommended as an option for treating chronic hepatitis C. Additional minor maintenance was also carried out.

ISBN: 978-1-4731-5634-0